Noninvasive Methods of Assessing Nonalcoholic Fatty Liver Disease: What the Clinician Needs to Know

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 9, 2013, Pages 1205-1207

  Torres, Dawn M ^a   Harrison, Stephen A ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

AGING; BODY MASS; CAUCASIAN; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EDITORIAL; FATTY LIVER INDEX; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LIPID STORAGE; NETHERLANDS; NONALCOHOLIC FATTY LIVER; PROGNOSIS; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND; WAIST CIRCUMFERENCE;

CLINICAL MEDICINE; FATTY LIVER; FEMALE; HUMANS; MALE;

EID: 84882846460     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.05.040     Document Type: Editorial

References (19)

1. Torres D.M., Williams C.D., Harrison S.A. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012, 10:837-858.
2. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012, 142:1592-1609.
3. Williams C.D., Stengel J., Asike M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
4. Targher G., Bertolini L., Padovani R., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease in type 2 diabetic patients. Diabetes Care 2007, 30:1212-1218.
5. Adams L.A., Lymp J.F., St. Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
6. Angulo P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology 2011, 53:1792-1794.
7. Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. Hepatology 2005, 42:132-138.
8. White D.L., Kanwal F., El-Serag H.B. Association between nonalcoholic fatty liver disease and risk for hepatocellular carcinoma, based on systematic review. Clin Gastroenterol Hepatol 2012, 12:1342-1359.
9. Adams L.A., Feldstein A.E. Non-invasive diagnosis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Dig Dis 2011, 12:10-16.
10. Koehler E.M., Schouten J.N.L., Hansen B.E., et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol 2013, 11:1201-1204.
11. Bedogni G., Bellentani S., Miglioli L., et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastro 2006, 6:33.
12. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ 1986, 292:13-15.
13. Graif M., Yanuka M., Baraz M., Blank A., et al. Quantitative estimate of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000, 35:319-324.
14. Palmentieri B., de Sio I., La Mura V., et al. The role of bright echo liver pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Dis 2006, 38:485-489.
15. Ryan C.K., Johnson L.A., Germin B.I., Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transp 2002, 8:1114-1122.
16. Machado M.V., Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 2013, 58:1007-1019.
17. Calori G., Lattuada G., Ragogna F., et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011, 54:145-152.
18. Adams L.A., George J., Bugianesi E., et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011, 26:1536-1543.
19. Dowman J.K., Tomlinson J.S., Newsome P.N. Systematic review: the diagnosis and stage of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011, 33:525-540.